Neurology® Podcast

Dr. Justin Abbatemarco talks with Dr. Daniel Ontaneda about the 2024 revisions of the McDonald criteria for diagnosing multiple sclerosis. Read the related article in The Lancet Neurology. Disclosures can be found at Neurology.org.

Dr. Deanna Saylor talks with Dr. Senjuti Saha about colonialism in global health and the importance of pathogen genomics. Read the related article in The Lancet. Disclosures can be found at Neurology.org.

In the second part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about legal and ethical considerations, the importance of interdisciplinary support, and the emotional impact on clinicians. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.

In the first part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about the background of the study, the definition and practice of MAID, and the main reasons that lead ALS patients to consider it. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about overcoming funding challenges, the importance of rigor and reputation, unmet needs in neurology, and leveraging AI in neurology research. Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities. Disclosures can be found at Neurology.org.

In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research. Disclosures can be found at Neurology.org.

In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice. Disclosures can be found at Neurology.org.

The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. The replay concludes with Dr. Katie Krulisky's conversation with Dr. Leah Blank on how outpatient follow-up impacts readmission rates in older adults with epilepsy or seizures Podcast links: The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation Understanding Acute Symptomatic Seizures Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge Article links: The Effect of Epilepsy Surgery on Tonic–Clonic Seizures Patient Perspectives on Antiseizure Medication Discontinuation Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older Disclosures can be found at Neurology.org.